Clinical Trial Results:
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
|
Summary
|
|
EudraCT number |
2010-020620-22 |
Trial protocol |
FR AT DE BE ES IT |
Global completion date |
21 Feb 2013
|
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Feb 2017
|
First version publication date |
05 Feb 2017
|
Other versions |
|
Summary report(s) |
jasint1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.